These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1130 related articles for article (PubMed ID: 33706836)

  • 1. Povidone-iodine preprocedural rinse-An evidence-based, second-line defense against severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in dental healthcare.
    Maurya RK; Singh H; Kapoor P; Sharma P; Srivastava D
    Infect Control Hosp Epidemiol; 2022 Jun; 43(6):822-824. PubMed ID: 33706836
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse.
    Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
    J Prosthodont; 2020 Jul; 29(6):529-533. PubMed ID: 32511851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
    Pelletier JS; Tessema B; Frank S; Westover JB; Brown SM; Capriotti JA
    Ear Nose Throat J; 2021 Apr; 100(2_suppl):192S-196S. PubMed ID: 32951446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses.
    Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
    J Prosthodont; 2020 Aug; 29(7):599-603. PubMed ID: 32608097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era.
    Frank S; Capriotti J; Brown SM; Tessema B
    Ear Nose Throat J; 2020 Nov; 99(9):586-593. PubMed ID: 32520599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic and therapeutic topical povidone-iodine in coronavirus disease 2019 (COVID-19): What is the evidence?
    Yan CH; Bleier BS
    Int Forum Allergy Rhinol; 2020 Dec; 10(12):1271-1273. PubMed ID: 33118690
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinse.
    Shet M; Westover J; Hong R; Igo D; Cataldo M; Bhaskar S
    BMC Oral Health; 2022 Feb; 22(1):47. PubMed ID: 35216566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gargling with povidone iodine has a short-term inhibitory effect on SARS-CoV-2 in patients with COVID-19.
    Seikai T; Takada A; Hasebe A; Kajihara M; Okuya K; Sekiguchi Yamada T; Kakuguchi W; Konno S; Ohiro Y
    J Hosp Infect; 2022 May; 123():179-181. PubMed ID: 35041895
    [No Abstract]   [Full Text] [Related]  

  • 9. The short-term effect of different chlorhexidine forms versus povidone iodine mouth rinse in minimizing the oral SARS-CoV-2 viral load: An open label randomized controlled clinical trial study.
    Natto ZS; Bakhrebah MA; Afeef M; Al-Harbi S; Nassar MS; Alhetheel AF; Ashi H
    Medicine (Baltimore); 2022 Jul; 101(30):e28925. PubMed ID: 35905275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing povidone-iodine to reduce the risk of SARS-CoV-2 infection and transmission: a narrative review.
    Lim NA; Teng O; Ng CYH; Bao LXY; Tambyah PA; Quek AML; Seet RCS
    Ann Med; 2022 Dec; 54(1):1488-1499. PubMed ID: 35594333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of oral antiseptics for SARS-CoV-2 infection.
    Palop Larrea V; Hernández Rodríguez MÁ
    Med Clin (Barc); 2020 Nov; 155(9):416-417. PubMed ID: 32778429
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical Ocular Povidone-Iodine as an Adjunctive Preventative Practice in the Era of COVID-19.
    O'Brien TP; Pelletier J
    Asia Pac J Ophthalmol (Phila); 2021 Mar; 10(2):142-145. PubMed ID: 33793439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Povidone-Iodine as a Pre-Procedural Mouthwash to Reduce the Salivary Viral Load of SARS-CoV-2: A Systematic Review of Randomized Controlled Trials.
    Garcia-Sanchez A; Peña-Cardelles JF; Ordonez-Fernandez E; Montero-Alonso M; Kewalramani N; Salgado-Peralvo AO; Végh D; Gargano A; Parra G; Guerra-Guajardo LI; Kozuma W
    Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of Topical Povidone-iodine to Decrease Viral Load of COViD-19.
    Benson KM; Mancini AA; Brodeur MR
    Sr Care Pharm; 2021 May; 36(5):238-241. PubMed ID: 33879284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Povidone-iodine solution as SARS-CoV-2 prophylaxis for procedures of the upper aerodigestive tract a theoretical framework.
    Naqvi SHS; Citardi MJ; Cattano D; Ostrosky-Zeichner L; Knackstedt MI; Karni RJ
    J Otolaryngol Head Neck Surg; 2020 Oct; 49(1):77. PubMed ID: 33109269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic.
    Khan MM; Parab SR; Paranjape M
    Am J Otolaryngol; 2020; 41(5):102618. PubMed ID: 32574894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the use of nasal and oral antiseptics during a global pandemic.
    Stathis C; Victoria N; Loomis K; Nguyen SA; Eggers M; Septimus E; Safdar N
    Future Microbiol; 2021 Jan; 16(2):119-130. PubMed ID: 33464122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of antiseptic mouthrinses against SARS-CoV-2: A prospective randomized placebo-controlled pilot study.
    Fantozzi PJ; Pampena E; Pierangeli A; Oliveto G; Sorrentino L; Di Vanna D; Pampena R; Lazzaro A; Gentilini E; Mastroianni CM; D'Ettorre G; Polimeni A; Romeo U; Villa A
    Am J Otolaryngol; 2022; 43(6):103549. PubMed ID: 35988522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Povidone-iodine gargle as a prophylactic intervention to interrupt the transmission of SARS-CoV-2.
    Pattanshetty S; Narayana A; Radhakrishnan R
    Oral Dis; 2021 Apr; 27 Suppl 3(Suppl 3):752-753. PubMed ID: 32352615
    [No Abstract]   [Full Text] [Related]  

  • 20. Utility of mouth rinses with povidone-iodine and hydrogen peroxide in patients with COVID-19.
    Pablo-Marcos D; Abascal B; Lloret L; Gutiérrez Cuadra M; Velasco N; Valero C
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 Mar; 41(3):173-175. PubMed ID: 36058840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.